Enphase Energy, Inc. (ENPH, Financial)
The price of Enphase Energy, Inc. (ENPH, Financial)Â stock surged in extended trading activity on Tuesday, after the company delivered another quarter of profitability on its unaudited financial results, driven by a combination of strong revenue growth, gross margin expansion and operating expense leverage.
For the fourth quarter 2014, ENPH posted record revenue of $105.2 million, a 57% increase year over year, and non-GAAP net income of $3.5 million, or $0.07 per diluted share, compared to a non-GAAP net loss of $0.7 million, or a loss of ($0.02) per diluted share in the same period the prior year, these results better than the Capital IQ Consensus Estimate of $0.03 earnings per share on revenues of $100.43 million.
According to its business outlook, ENPH expects revenue for the first quarter 2015 to be within a range of $84 million to $88 million. At the midpoint of the revenue outlook range, revenue would be up 49% compared to the first quarter of 2014.
ENPH delivers microinverter technology for the solar industry that increases energy production, simplifies design and installation, improves system uptime and reliability, reduces fire safety risk and provides a platform for intelligent energy management.
More about Enphase Energy, Inc. (ENPH, Financial) at www.enphase.com
**
Boston Scientific Corp. (BSX, Financial)
Shares of Boston Scientific Corp. (BSX, Financial)Â climbed more than 10% in after-hours trading on Tuesday, after it reported the settlement of the breach of merger agreement lawsuit brought by Johnson & Johnson (JNJ, Financial) against Guidant Corporation, stemming from BSX's acquisition of Guidant.
In the lawsuit filed in 2006, Johnson & Johnson alleged that Guidant breached the merger agreement it had with Johnson & Johnson, and sought more than $7 billion in damages. Guidant disputed the allegations. As a result of the settlement agreement, Johnson & Johnson has agreed to permanently dismiss its action without acknowledgment of liability by Guidant.
As part of the settlement, BSX will make aggregate payments totaling $600 million to Johnson & Johnson and BSX has agreed not to bring patent infringement or other claims related to certain Johnson & Johnson's stent products
BSX transforms lives through innovative medical solutions that improve the health of patients around the world. BSX advances science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
More about Boston Scientific Corp. (BSX, Financial) at www.bostonscientific.com
**
Crown Equity Holdings Inc. (CRWE, Financial)
Crown Equity Holdings Inc. (CRWE, Financial)Â provides marketing solutions that boost customer awareness and merchant visibility on the Internet. The company is currently developing its CRWE Network (www.CRWE-PR.com), a growing network of community targeted sites.
It has recently included Norwalk, California (www.norwalk.crwe-pr.com) into the CRWENetwork.
Norwalk is located 17 miles (27 km) southeast of downtown Los Angeles. Norwalk is where California history intersects with new millennium technology in Southern California.
The City of Norwalk had an estimated population in 2013 (U.S. Census Bureau) of 106,589, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally.
The CRWE Network has reached the 1,487th community website in the U.S. and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.
The CRWE-PR Business Directory portal (www.BusinessDirectory.crwe-pr.com) is the company’s business directory service that is available to all United States and Canada business in the public and private sector. It allows business owners and executives the ability to claim their business listings and provide more detailed information for their potential customers who visit the CRWE Network every day.
More about Crown Equity Holdings Inc. (CRWE, Financial) at www.crownequityholdings.com
**
Disclaimer: CRWE-PR Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer
